Cancer Screening – Male

3 Tests | Rs 999 | Blood Tests Only | Fasting Not Needed | Reports In 15 Hours
Powered By Redcliffelabs CA 19.9, CEA, PSA
  1. CA 19.9 (Pancreatic Cancer Marker) (1)
    1. Ca 19.9
  2. Carcinoembryonic Antigen (CEA). (1)
    1. CEA
  3. Prostate Specific Antigen (PSA) Total (1)
    1. PSA – Total (Prostate Specific Antigen)

 

The “Cancer Screening – Male” package offered by Redcliffelabs is specifically designed for males and focuses on screening for certain cancer markers. This package includes 3 blood tests that are aimed at detecting potential signs of cancer. The reports for these tests are typically available within 15 hours. Here are the details of the tests included in this package:

Explanation of Tests:

  1. CA 19.9 (Pancreatic Cancer Marker): This test measures the level of CA 19.9 antigen in the blood. Elevated CA 19.9 levels can indicate the presence of pancreatic cancer or other conditions.
  2. Carcinoembryonic Antigen (CEA): CEA is a protein that may be elevated in individuals with certain types of cancer, including colorectal, lung, and breast cancer. The test measures the levels of CEA in the blood.
  3. Prostate Specific Antigen (PSA) Total: PSA is a protein produced by the prostate gland. Elevated PSA levels can be an indicator of prostate cancer. However, PSA levels can also be affected by other factors, such as prostate enlargement or inflammation.

Benefits of the Cancer Screening – Male Package:

  • Early Detection: These tests are designed to detect potential cancer markers at an early stage, which can contribute to early intervention and improved outcomes.
  • Tailored for Men: This package focuses on cancer markers that are particularly relevant for men, such as prostate-specific antigen (PSA).

Who Should Opt for This Package:

  • Men who want to proactively screen for potential cancer markers.
  • Individuals who have a family history of cancer and want to monitor their health closely.
  • People who may have risk factors for certain cancers and wish to assess their cancer risk.

 

It’s important to note that while cancer screening tests can provide valuable information, they may not provide a definitive diagnosis on their own. Elevated marker levels do not necessarily mean cancer is present, as other factors can influence test results. If any test results are outside the normal range, it’s recommended to consult with a healthcare professional for further evaluation and guidance. Additionally, cancer screening is just one aspect of maintaining overall health, and regular check-ups, a healthy lifestyle, and personalized medical advice are crucial components of comprehensive healthcare.